A study of over 450,000 NSTEMI admissions reveals that diabetics face disparities in care, with less invasive treatment ...

The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...

The following is a summary of “Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction—A Matched Case-Control Study,” published in the October ...

While women are thought to generally have greater protection than men against CVD due to estrogen, women have been shown to ...

What are the top symptoms of a heart attack in women? Chest pain, upper body discomfort, fatigue, and more. Learn to spot the ...

People with dementia are almost twice as likely to move following receipt of the diagnosis compared with individuals ...

Sensitivity HEART Pathway Safely Reduces Hospitalizations Regardless of Sex or Race in a Multisite Prospective US Cohort,” ...

(HealthDay News) — COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as ...

Results of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with ...

In patients with axial spondyloarthritis and a history of cardiovascular events, recurrent cardiovascular events were ...

Oral glucose tolerance test demonstrated better prognostic value in detecting dysglycemia than HbA1c in coronary artery disease.

ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...